Skip to main content
. Author manuscript; available in PMC: 2018 Apr 27.
Published in final edited form as: Eur J Epidemiol. 2016 Jun 14;31(9):893–904. doi: 10.1007/s10654-016-0169-z

Table 1.

Selected cohort characteristics

EPIC-Elderly
Germany (ESTHER) Northern Ireland (PRIME Belfast) Norway (Tromsø) USA (NIH AARP)
Denmark Greece Netherlands Spain
Baseline characteristics (n=6,871) (n=6,877) (n=4,149) (n=4,550) (n=8347) (n=1,920) (n=5,849) (n=291,013)
Recruitment year (range) 1993-1997 1994-1999 1993-1997 1992-1996 2000-2003 1991-1994 1994-1995 1995-1997
Mean age, in years (SD) 62.5 1.5 67.0 4.4 64.3 2.8 62.5 1.7 61.8 6.6 54.2 2.8 59.4 6.9 62.2 5.3
Sex
 Men 3521 51.2% 2693 39.2% 154 3.7% 1931 42.4% 3784 45.3% 1920 100.0% 2736 46.8% 173053 59.5%
 Women 3350 48.8% 4184 60.8% 3995 96.3% 2619 57.6% 4563 54.7% 0 0.0% 3113 53.2% 117960 40.5%
Education
 Low (primary or less) 2451 35.7% 6281 91.3% 1279 30.8% 3899 85.7% 6025 72.2% 15 0.8% 2999 51.3% 1391 0.5%
 Medium (more than primary but less than college) 3040 44.2% 379 5.5% 2364 57.0% 317 7.0% 1736 20.8% 1655 86.2% 1710 29.2% 64968 22.3%
 High (college or university) 1366 19.9% 200 2.9% 503 12.1% 284 6.2% 412 4.9% 250 13.0% 1108 18.9% 218567 75.1%
 Missing 14 0.2% 17 0.2% 3 0.1% 50 1.1% 174 2.1% 0 0.0% 32 0.5% 6087 2.1%
Mean BMI at baseline (SD) 26.1 3.8 29.3 4.3 25.8 3.9 29.5 4.0 27.6 4.2 26.1 3.2 26.1 3.7 26.8 4.5
 Underweight (BMI < 18.5) 35 0.5% 18 0.3% 45 1.1% 4 0.1% 33 0.4% 8 0.4% 43 0.7% 2448 0.8%
 Normal weight (BMI ≥ 18.5 & BMI < 25) 2819 41.0% 1062 15.4% 1891 45.6% 491 10.8% 2268 27.2% 717 37.3% 2352 40.2% 105194 36.1%
 Overweight (BMI ≥ 25 & BMI < 30) 3096 45.1% 2997 43.6% 1674 40.3% 2151 47.3% 3953 47.4% 980 51.0% 2634 45.0% 123544 42.5%
 Obese (BMI ≥ 30) 921 13.4% 2800 40.7% 539 13.0% 1904 41.8% 2093 25.1% 215 11.2% 820 14.0% 59827 20.6%
Vigorous physical activitya
 No 1742 25.4% 5418 78.8% 1669 40.2% 4308 94.7% 4678 56.0% 1668 86.9% 3526 60.3% 150872 51.8%
 Yes 5129 74.6% 1459 21.2% 2480 59.8% 242 5.3% 3669 44.0% 252 13.1% 2323 39.7% 140141 48.2%
Alcohol intake (average daily consumption in grams) 20.2 7.4 7.8 13.0 6.8 20 3.6 13.3
 N missing 0 0.0% 0 0.0% 0 0.0% 0 0.0% 664 8.0% 0 0.0% 1082 18.5% 0 0.0%
Smoking statusa
 Never daily smoker 2293 33.4% 4830 70.2% 2002 48.3% 3095 68.0% 4188 50.2% 792 41.3% 1935 33.1% 106549 36.6%
 Former daily smoker 2650 38.6% 1257 18.3% 1482 35.7% 722 15.9% 2771 33.2% 637 33.2% 2107 36.0% 151248 52.0%
 Current daily smoker 1928 28.1% 790 11.5% 665 16.0% 733 16.1% 1388 16.6% 491 25.6% 1807 30.9% 33216 11.4%
Hormone therapy useb
 Ever 1686 50.3% 0 0.0% 3299 82.6% 2310 88.2% 1965 43.1% n/a 1475 47.4% 52021 44.1%
 Never 1564 46.7% 0 0.0% 692 17.3% 288 11.0% 2287 50.1% n/a 873 28.0% 65939 55.9%
 Missing 100 3.0% 4184 100.0% 4 0.1% 21 0.8% 311 6.8% n/a 765 24.6% 0 0.0%
Self-reported or documented diabetes type 2
 No 6429 93.6% 5924 86.1% 3986 96.1% 4026 88.5% n/a n/a n/a 266601 91.6%
 Yes 143 2.1% 944 13.7% 159 3.8% 515 11.3% n/a n/a n/a 24412 8.4%
 Missing 299 4.4% 9 0.1% 4 0.1% 9 0.2% n/a n/a n/a 0 0.0%
Median follow-up time (years) 11.9 11.5 13.2 13.4 10.4 18.0 15.9 10.5
N cancers cases (N/incidence ratec per 100 000) 734 340 403 483 845 256 722 53094
 N breast cancer (age>50, women only) 110 42.4 21 9.3 109 57.0 42 21.4 120 86.0 0 0.0 64 39.1 5903 152.9
 N colorectal cancer 94 37.4 37 10.1 77 39.3 66 35.1 110 67.8 40 75.3 112 53.9 4469 93.5
 N other obesity-relatedd 76 30.3 65 25.4 56 27.5 56 28.1 113 70.2 15 29.3 64 34.3 4701 104.7
 N obesity-relatede 280 110.0 123 44.7 242 123.7 164 84.6 343 224.0 55 104.6 240 127.4 15073 351.1
a

participants with missing information on physical activity and smoking status were excluded;

b

women only

c

age-standardized to the World standard population;

d

pancreas, kidney, gallbladder, endometrium, ovary, liver, lower oesophagus, cardia stomach

e

other obesity-related sites plus breast and colorectal cancer